The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Terminally Ill

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Terminally Ill

 

Psychiatry related information on Terminally Ill

  • In essence, Buchanan rejects Annas's argument that, taken together, the Saikewicz opinion and the Quinlan opinion of the Supreme Court of New Jersey delineate a proper division of medical and legal decision-making responsibility concerning terminally ill incompetents [6].
 

High impact information on Terminally Ill

  • On the other hand, prolongation of pain and suffering for the terminally ill cancer patient is obviously not an indication for TPN [7].
  • We conclude that Medicare's PPS resulted in the increased transfer of terminally ill patients from hospitals to nursing homes [8].
  • Law-medicine notes. Laetrile for the terminally ill: Supreme Court stops the nonsense [9].
  • OBJECTIVE--To determine the frequency of symptoms of hunger and thirst in a group of terminally ill patients and determine whether these symptoms could be palliated without forced feeding, forced hydration, or parenteral alimentation [10].
  • Withholding of life-sustaining treatment from the terminally ill, incompetent patient: who decides? Part II [11].
 

Chemical compound and disease context of Terminally Ill

 

Biological context of Terminally Ill

 

Anatomical context of Terminally Ill

 

Associations of Terminally Ill with chemical compounds

  • Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine [19].
  • Three acute high-dose animals received 2.0 mg methylmercury for 17 to 18 days, when they became terminally ill [20].
  • Pirfenidone, a new, investigational antifibrotic agent, was evaluated for its tolerability and usefulness in terminally ill patients with advanced IPF [21].
  • In a terminally ill patient given 30 mg/d for 361 d, plasma and tissue (x+/-SD) RRR-rac ratios (and % deuterated alpha-tocopherol) at autopsy were 2.06 (6.3%) and 1.71+/-0.24 (5.9+/-2.2%), respectively [22].
  • In terminally ill mice, there was also a 2.5-fold increase in both total ubiquinone and its reduced form [23].
 

Gene context of Terminally Ill

  • This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals [24].
  • Intrathecal somatostatin in terminally ill patients. A report of two cases [25].
  • Although elevated serum S100 beta levels were consistently observed in terminally ill animals for both routes of infection, the experiments failed to detect significantly increased S100 beta serum concentrations prior to the manifestation of clinical symptoms [26].
  • The relationship between vitamin B12 levels and survival was studied in a group of 161 terminally ill cancer patients who were recruited consecutively between 1988 and 1989 [27].
  • In contrast, plasma IL-6 was detectable from days 4 to 9 and was detectable in colonic tissue in only a few (two of four) terminally ill animals on day 9 [28].
 

Analytical, diagnostic and therapeutic context of Terminally Ill

References

  1. Nitrous oxide analgesia for refractory pain in the terminally ill. Fosburg, M.T., Crone, R.K. JAMA (1983) [Pubmed]
  2. A model for spontaneous B-lineage lymphomas in IgHmu-HOX11 transgenic mice. Hough, M.R., Reis, M.D., Singaraja, R., Bryce, D.M., Kamel-Reid, S., Dardick, I., Breitman, M.L., Dubé, I.D. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  3. Effect of nebulized furosemide in terminally ill cancer patients with dyspnea. Kohara, H., Ueoka, H., Aoe, K., Maeda, T., Takeyama, H., Saito, R., Shima, Y., Uchitomi, Y. Journal of pain and symptom management. (2003) [Pubmed]
  4. Enhanced levels of scrapie responsive gene mRNA in BSE-infected mouse brain. Dandoy-Dron, F., Benboudjema, L., Guillo, F., Jaegly, A., Jasmin, C., Dormont, D., Tovey, M.G., Dron, M. Brain Res. Mol. Brain Res. (2000) [Pubmed]
  5. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Mystakidou, K., Tsilika, E., Kalaidopoulou, O., Chondros, K., Georgaki, S., Papadimitriou, L. Anticancer Res. (2002) [Pubmed]
  6. Medical paternalism or legal imperialism: not the only alternatives for handling Saikewicz-type cases. Buchanan, A. American journal of law & medicine. (1979) [Pubmed]
  7. Hyperalimentation in cancer. Souba, W.W., Copeland, E.M. CA: a cancer journal for clinicians. (1989) [Pubmed]
  8. Changes in the location of death after passage of Medicare's prospective payment system. A national study. Sager, M.A., Easterling, D.V., Kindig, D.A., Anderson, O.W. N. Engl. J. Med. (1989) [Pubmed]
  9. Law-medicine notes. Laetrile for the terminally ill: Supreme Court stops the nonsense. Curran, W.J. N. Engl. J. Med. (1980) [Pubmed]
  10. Comfort care for terminally ill patients. The appropriate use of nutrition and hydration. McCann, R.M., Hall, W.J., Groth-Juncker, A. JAMA (1994) [Pubmed]
  11. Withholding of life-sustaining treatment from the terminally ill, incompetent patient: who decides? Part II. Suber, D.G., Tabor, W.J. JAMA (1982) [Pubmed]
  12. Long-lasting epidural sensory blockade by n-butyl-p-aminobenzoate in the terminally ill intractable cancer pain patient. Korsten, H.H., Ackerman, E.W., Grouls, R.J., van Zundert, A.A., Boon, W.F., Bal, F., Crommelin, M.A., Ribot, J.G., Hoefsloot, F., Slooff, J.L. Anesthesiology (1991) [Pubmed]
  13. Torsades de pointes caused by a small dose of risperidone in a terminally ill cancer patient. Tei, Y., Morita, T., Inoue, S., Miyata, H. Psychosomatics. (2004) [Pubmed]
  14. Management of constipation in terminally ill patients. Crowther, A.G. J. Int. Med. Res. (1978) [Pubmed]
  15. Acyclovir prophylaxis in bone marrow transplant recipients. Lundgren, G., Wilczek, H., Lönnqvist, B., Lindholm, A., Wahren, B., Ringdén, O. Scandinavian journal of infectious diseases. Supplementum. (1985) [Pubmed]
  16. Radiation protection consequences of the care of a terminally ill patient having received a thyroid ablation dose of 131I-sodium iodide. Griffiths, P.A., Jones, G.P., Marshall, C., Powley, S.K. The British journal of radiology. (2000) [Pubmed]
  17. Intratesticular transplantation of testicular cells from leukemic rats causes transmission of leukemia. Jahnukainen, K., Hou, M., Petersen, C., Setchell, B., Söder, O. Cancer Res. (2001) [Pubmed]
  18. Subpial vacuolar myelopathy after intrathecal ketamine: report of a case. Karpinski, N., Dunn, J., Hansen, L., Masliah, E. Pain (1997) [Pubmed]
  19. Assessing and managing depression in the terminally ill patient. ACP-ASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Block, S.D. Ann. Intern. Med. (2000) [Pubmed]
  20. Primate paneth cell degeneration following methylmercury hydroxide ingestion. Mottet, N.K., Body, R.L. Am. J. Pathol. (1976) [Pubmed]
  21. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone: results of a prospective, open-label Phase II study. Raghu, G., Johnson, W.C., Lockhart, D., Mageto, Y. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  22. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. Burton, G.W., Traber, M.G., Acuff, R.V., Walters, D.N., Kayden, H., Hughes, L., Ingold, K.U. Am. J. Clin. Nutr. (1998) [Pubmed]
  23. Lipid composition in scrapie-infected mouse brain: prion infection increases the levels of dolichyl phosphate and ubiquinone. Guan, Z., Söderberg, M., Sindelar, P., Prusiner, S.B., Kristensson, K., Dallner, G. J. Neurochem. (1996) [Pubmed]
  24. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.C., Brandner, S., Collinge, J. Science (2003) [Pubmed]
  25. Intrathecal somatostatin in terminally ill patients. A report of two cases. Meynadier, J., Chrubasik, J., Dubar, M., Wünsch, E. Pain (1985) [Pubmed]
  26. Late increase of serum S100 beta protein levels in hamsters after oral or intraperitoneal infection with scrapie. Beekes, M., Otto, M., Wiltfang, J., Bahn, E., Poser, S., Baier, M. J. Infect. Dis. (1999) [Pubmed]
  27. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. Geissbühler, P., Mermillod, B., Rapin, C.H. Journal of pain and symptom management. (2000) [Pubmed]
  28. Antiserum to tumor necrosis factor and failure to prevent murine colitis. Olson, A.D., DelBuono, E.A., Bitar, K.N., Remick, D.G. J. Pediatr. Gastroenterol. Nutr. (1995) [Pubmed]
  29. Terminal nutrition: framing the debate for the withdrawal of nutritional support in terminally ill patients. Winter, S.M. Am. J. Med. (2000) [Pubmed]
  30. Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Todorova, M.T., Dangler, C.A., Drage, M.G., Sheppard, B.J., Fox, J.G., Seyfried, T.N. Epilepsia (2003) [Pubmed]
  31. Correlation of the dose of midazolam for symptom control with administration periods: the possibility of tolerance. Morita, T., Tei, Y., Inoue, S. Journal of pain and symptom management. (2003) [Pubmed]
  32. Total parenteral nutrition for a terminally ill patient? Fainsinger, R.L., Chan, K., Bruera, E. Journal of palliative care. (1992) [Pubmed]
 
WikiGenes - Universities